Does reactogenicity after a second injection of the BNT162b2 vaccine predict spike IgG antibody levels in healthy Japanese subjects?

Masaaki Takeuchi, Yukie Higa, Akina Esaki, Yosuke Nabeshima, Akemi Nakazono
doi: https://doi.org/10.1101/2021.06.08.21258444

Article Information

doi 
https://doi.org/10.1101/2021.06.08.21258444
History 
  • June 10, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Masaaki Takeuchi1,&,
  2. Yukie Higa1,
  3. Akina Esaki1,
  4. Yosuke Nabeshima2 and
  5. Akemi Nakazono1
  1. 1Department of Laboratory and Transfusion Medicine, Hospital of University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
  2. 2Second Department of Internal Medicine, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
  1. ↵&Address for correspondence: Masaaki Takeuchi, Department of Laboratory and Transfusion Medicine, Hospital of University of Occupational and Environmental Health, School of Medicine, 1-1 Iseigaoka, Yahatanishi, Kitakyushu, 807-8555 Japan, Phone: +81-93-603-1611, E-mail: takeuchi{at}med.uoeh-u.ac.jp
Back to top
Posted June 10, 2021.
Download PDF
Data/Code
Email
Does reactogenicity after a second injection of the BNT162b2 vaccine predict spike IgG antibody levels in healthy Japanese subjects?
Masaaki Takeuchi, Yukie Higa, Akina Esaki, Yosuke Nabeshima, Akemi Nakazono
medRxiv 2021.06.08.21258444; doi: https://doi.org/10.1101/2021.06.08.21258444
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area